Zaret KS - Search Results

1

Reprogramming of human cancer cells to pluripotency for models of cancer progression.

Kim J, Zaret KS. Kim J, et al. Among authors: zaret ks. EMBO J. 2015 Mar 12;34(6):739-47. doi: 10.15252/embj.201490736. Epub 2015 Feb 20. EMBO J. 2015. PMID: 25712212 Free PMC article. Review.

2

Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.

Soufi A, Donahue G, Zaret KS. Soufi A, et al. Among authors: zaret ks. Cell. 2012 Nov 21;151(5):994-1004. doi: 10.1016/j.cell.2012.09.045. Epub 2012 Nov 15. Cell. 2012. PMID: 23159369 Free PMC article.

3

Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.

Soufi A, Zaret KS. Soufi A, et al. Among authors: zaret ks. Cell Cycle. 2013 May 15;12(10):1487-91. doi: 10.4161/cc.24663. Epub 2013 Apr 19. Cell Cycle. 2013. PMID: 23603987 Free PMC article.

4

An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.

Kim J, Hoffman JP, Alpaugh RK, Rhim AD, Reichert M, Stanger BZ, Furth EE, Sepulveda AR, Yuan CX, Won KJ, Donahue G, Sands J, Gumbs AA, Zaret KS. Kim J, et al. Among authors: zaret ks. Cell Rep. 2013 Jun 27;3(6):2088-99. doi: 10.1016/j.celrep.2013.05.036. Epub 2013 Jun 20. Cell Rep. 2013. PMID: 23791528 Free PMC article.

5

Dynamics of genomic H3K27me3 domains and role of EZH2 during pancreatic endocrine specification.

Xu CR, Li LC, Donahue G, Ying L, Zhang YW, Gadue P, Zaret KS. Xu CR, et al. Among authors: zaret ks. EMBO J. 2014 Oct 1;33(19):2157-70. doi: 10.15252/embj.201488671. Epub 2014 Aug 8. EMBO J. 2014. PMID: 25107471 Free PMC article.

6

Pioneer transcription factors in cell reprogramming.

Iwafuchi-Doi M, Zaret KS. Iwafuchi-Doi M, et al. Among authors: zaret ks. Genes Dev. 2014 Dec 15;28(24):2679-92. doi: 10.1101/gad.253443.114. Genes Dev. 2014. PMID: 25512556 Free PMC article. Review.

7

Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming.

Soufi A, Garcia MF, Jaroszewicz A, Osman N, Pellegrini M, Zaret KS. Soufi A, et al. Among authors: zaret ks. Cell. 2015 Apr 23;161(3):555-568. doi: 10.1016/j.cell.2015.03.017. Epub 2015 Apr 16. Cell. 2015. PMID: 25892221 Free PMC article.

8

H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes.

Becker JS, Nicetto D, Zaret KS. Becker JS, et al. Among authors: zaret ks. Trends Genet. 2016 Jan;32(1):29-41. doi: 10.1016/j.tig.2015.11.001. Epub 2015 Dec 8. Trends Genet. 2016. PMID: 26675384 Free PMC article. Review.

9

Cell fate control by pioneer transcription factors.

Iwafuchi-Doi M, Zaret KS. Iwafuchi-Doi M, et al. Among authors: zaret ks. Development. 2016 Jun 1;143(11):1833-7. doi: 10.1242/dev.133900. Development. 2016. PMID: 27246709 Free PMC article. Review.

10

Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.

Kim J, Bamlet WR, Oberg AL, Chaffee KG, Donahue G, Cao XJ, Chari S, Garcia BA, Petersen GM, Zaret KS. Kim J, et al. Among authors: zaret ks. Sci Transl Med. 2017 Jul 12;9(398):eaah5583. doi: 10.1126/scitranslmed.aah5583. Sci Transl Med. 2017. PMID: 28701476 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters